Stocks and InvestingStocks and Investing
Thu, March 12, 2020
Wed, March 11, 2020
Tue, March 10, 2020
Mon, March 9, 2020

Kevin Huang Upgraded (BSX) to Strong Buy and Decreased Target to $47 on, Mar 9th, 2020


Published on 2024-10-26 23:24:09 -
  Print publication without navigation


Kevin Huang of CFRA, Upgraded "Boston Scientific Corporation" (BSX) to Strong Buy and Decreased Target from $50 to $47 on, Mar 9th, 2020.

Kevin has made no other calls on BSX in the last 4 months.



There are 7 other peers that have a rating on BSX. Out of the 7 peers that are also analyzing BSX, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $46 on, Thursday, February 13th, 2020


These are the ratings of the 6 analyists that currently disagree with Kevin


  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $46 on, Friday, March 6th, 2020
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $52 on, Monday, December 30th, 2019
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Friday, December 20th, 2019
  • Mike Matson of "Needham" Downgraded at Strong Buy on, Thursday, December 19th, 2019
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $51 on, Tuesday, December 17th, 2019
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $52 on, Monday, December 16th, 2019